- Home
- LEGN vs CFR Comparison
LEGN vs CFR Comparison
Compare LEGN & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- CFR
- Stock Information
- Founded
- LEGN 2014
- CFR 1868
- Country
- LEGN United States
- CFR United States
- Employees
- LEGN N/A
- CFR N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- CFR Major Banks
- Sector
- LEGN Health Care
- CFR Finance
- Exchange
- LEGN Nasdaq
- CFR Nasdaq
- Market Cap
- LEGN 7.0B
- CFR 7.9B
- IPO Year
- LEGN 2020
- CFR N/A
- Fundamental
- Price
- LEGN $28.91
- CFR $126.46
- Analyst Decision
- LEGN Strong Buy
- CFR Hold
- Analyst Count
- LEGN 13
- CFR 15
- Target Price
- LEGN $75.67
- CFR $131.93
- AVG Volume (30 Days)
- LEGN 1.7M
- CFR 383.1K
- Earning Date
- LEGN 05-13-2025
- CFR 05-01-2025
- Dividend Yield
- LEGN N/A
- CFR 3.17%
- EPS Growth
- LEGN N/A
- CFR 7.71
- EPS
- LEGN N/A
- CFR 9.11
- Revenue
- LEGN $728,303,000.00
- CFR $2,038,108,000.00
- Revenue This Year
- LEGN $64.21
- CFR $13.57
- Revenue Next Year
- LEGN $53.69
- CFR $4.58
- P/E Ratio
- LEGN N/A
- CFR $13.87
- Revenue Growth
- LEGN 112.46
- CFR 5.45
- 52 Week Low
- LEGN $27.34
- CFR $94.09
- 52 Week High
- LEGN $60.87
- CFR $147.64
- Technical
- Relative Strength Index (RSI)
- LEGN 39.95
- CFR 54.55
- Support Level
- LEGN $28.14
- CFR $129.20
- Resistance Level
- LEGN $31.12
- CFR $131.80
- Average True Range (ATR)
- LEGN 1.87
- CFR 2.27
- MACD
- LEGN -0.16
- CFR -0.09
- Stochastic Oscillator
- LEGN 25.95
- CFR 49.19
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $50 billion in assets (as of 2024 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.